International audienceOn October 2020, the US Food and Drug Administration (FDA) approved remdesivir as the first drug for the treatment of coronavirus disease 2019 (COVID-19), increasing remdesivir prescriptions worldwide. However, potential cardiovascular (CV) toxicities associated with remdesivir remain unknown. We aimed to characterize the CV adverse drug reactions (ADRs) associated with remdesivir using VigiBase, an individual case safety report database of the World Health Organization (WHO). Disproportionality analyses of CV-ADRs associated with remdesivir were performed using reported odds ratios and information components. We conducted in vitro experiments using cardiomyocytes derived from human pluripotent stem cell cardiomyocytes...
The COVID-19 pandemic has resulted in a complex clinical challenge, caused by a novel coronavirus, p...
On March 23, 2020, the Moroccan Ministry of Health issued a circular authorizing the off label use o...
Abstract Only a handful of US Food and Drug Administration (FDA) Emergency Use Authorizations exist ...
International audienceOn October 2020, the US Food and Drug Administration (FDA) approved remdesivir...
Remdesivir was recommended for hospitalized patients with COVID-19. As already reported in the Summa...
Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus-2 (SARS...
Objectives: Limited data are available regarding the occurrence and the extent of cardiac rhythm dis...
BACKGROUND: COVID-19 is an infectious disease caused by a coronavirus in humans, namely SARS-CoV-2, ...
The coronavirus disease 2019 (COVID-19) pandemic has been an enormous public health challenge. The p...
Remdesivir is a commonly used antiviral drug to treat COVID-19. Remdesivir has some side effects; ho...
Since December 2019, the novel coronavirus disease 2019 (COVID-19), caused by severe acute respirato...
Recently, remdesivir was approved by the United States Food and Drug Administration for patients wit...
Objectives: The aim of the study was to evaluate the adverse drug reactions (ADR) following Remdesiv...
Objectives: Remdesivir has shown promise in the management of patients with COVID-19 although recent...
International audienceRemdesivir has demonstrated clinical benefits in randomized placebo-controlled...
The COVID-19 pandemic has resulted in a complex clinical challenge, caused by a novel coronavirus, p...
On March 23, 2020, the Moroccan Ministry of Health issued a circular authorizing the off label use o...
Abstract Only a handful of US Food and Drug Administration (FDA) Emergency Use Authorizations exist ...
International audienceOn October 2020, the US Food and Drug Administration (FDA) approved remdesivir...
Remdesivir was recommended for hospitalized patients with COVID-19. As already reported in the Summa...
Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus-2 (SARS...
Objectives: Limited data are available regarding the occurrence and the extent of cardiac rhythm dis...
BACKGROUND: COVID-19 is an infectious disease caused by a coronavirus in humans, namely SARS-CoV-2, ...
The coronavirus disease 2019 (COVID-19) pandemic has been an enormous public health challenge. The p...
Remdesivir is a commonly used antiviral drug to treat COVID-19. Remdesivir has some side effects; ho...
Since December 2019, the novel coronavirus disease 2019 (COVID-19), caused by severe acute respirato...
Recently, remdesivir was approved by the United States Food and Drug Administration for patients wit...
Objectives: The aim of the study was to evaluate the adverse drug reactions (ADR) following Remdesiv...
Objectives: Remdesivir has shown promise in the management of patients with COVID-19 although recent...
International audienceRemdesivir has demonstrated clinical benefits in randomized placebo-controlled...
The COVID-19 pandemic has resulted in a complex clinical challenge, caused by a novel coronavirus, p...
On March 23, 2020, the Moroccan Ministry of Health issued a circular authorizing the off label use o...
Abstract Only a handful of US Food and Drug Administration (FDA) Emergency Use Authorizations exist ...